Cytokine expression profiles in Autism spectrum disorder: A multi-center study from Turkey
dc.contributor.author | Kutuk M.O. | |
dc.contributor.author | Tufan E. | |
dc.contributor.author | Gokcen C. | |
dc.contributor.author | Kilicaslan F. | |
dc.contributor.author | Karadag M. | |
dc.contributor.author | Mutluer T. | |
dc.contributor.author | Yektas C. | |
dc.contributor.author | Coban N. | |
dc.contributor.author | Kandemir H. | |
dc.contributor.author | Buber A. | |
dc.contributor.author | Coskun S. | |
dc.contributor.author | Acikbas U. | |
dc.contributor.author | Guler G. | |
dc.contributor.author | Topal Z. | |
dc.contributor.author | Celik F. | |
dc.contributor.author | Altintas E. | |
dc.contributor.author | Giray A. | |
dc.contributor.author | Aka Y. | |
dc.contributor.author | Kutuk O. | |
dc.date.accessioned | 2024-07-22T08:07:07Z | |
dc.date.available | 2024-07-22T08:07:07Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder characterized by impairments in communication and social interaction as well as restricted interests and repetitive behaviors. The pathogenesis of ASD is not completely understood, but a growing body of research has demonstrated that the immune response may be a contributing factor in the etiology and/ or ontogeny of ASD. The aim of this study was to determine the expression levels of IL-1β, IL-1α, IL-4, IL-6, IL-17, TNF-α and TGF-β in peripheral blood mononuclear cells of children with ASD and healthy controls in order to determine the contributions of cytokines to ASD. Within the study timeframe, 195 children with ASDs (80.5% male) and 162 controls (73.6% male) were enrolled. Most children with ASD had a comorbid disorder (n = 114, 58.5%), with the most common diagnoses as Intellectual Developmental Disorder (IDD, n = 64, 32.8%) and ADHD (n = 64, 32.8%). The majority of children with ASD had severe autistic symptoms as evaluated via Childhood Autism Rating Scale (CARS, n = 130, 64.6%). The mean CARS score in the ASD sample was 40.8 (S.D. = 7.6). The patients with ASD were found to have significantly higher levels of IL-6 (p < 0.001) and significantly lower levels of IL-17 (p < 0.05, all Bonferroni corrected). Treatment tended to affect IL-4 levels. Lastly, discriminant function analysis (DFA) revealed that a combination of IL-6, IL-17 and IL-1α correctly classified 56.6% of cases. Despite extensive immunological evidence suggesting immune system aberrations, further research is required to clarify the relationship between immune profiles and ASD symptoms. © 2020 Elsevier Ltd | |
dc.identifier.DOI-ID | 10.1016/j.cyto.2020.155152 | |
dc.identifier.issn | 10434666 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13840 | |
dc.language.iso | English | |
dc.publisher | Academic Press | |
dc.subject | Adult | |
dc.subject | Autism Spectrum Disorder | |
dc.subject | Autistic Disorder | |
dc.subject | Cells, Cultured | |
dc.subject | Child | |
dc.subject | Cytokines | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Immunity | |
dc.subject | Interleukin-1beta | |
dc.subject | Leukocytes, Mononuclear | |
dc.subject | Male | |
dc.subject | Turkey | |
dc.subject | cytokine | |
dc.subject | interleukin 17 | |
dc.subject | interleukin 1alpha | |
dc.subject | interleukin 1beta | |
dc.subject | interleukin 4 | |
dc.subject | interleukin 6 | |
dc.subject | messenger RNA | |
dc.subject | transforming growth factor beta | |
dc.subject | tumor necrosis factor | |
dc.subject | cytokine | |
dc.subject | interleukin 1beta | |
dc.subject | adolescent | |
dc.subject | Article | |
dc.subject | attention deficit disorder | |
dc.subject | autism | |
dc.subject | child | |
dc.subject | Childhood Autism Rating Scale | |
dc.subject | clinical evaluation | |
dc.subject | clinical feature | |
dc.subject | comorbidity | |
dc.subject | controlled study | |
dc.subject | developmental disorder | |
dc.subject | disease severity | |
dc.subject | female | |
dc.subject | gene expression | |
dc.subject | human | |
dc.subject | immune system | |
dc.subject | intellectual developmental disorder | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | multicenter study | |
dc.subject | peripheral blood mononuclear cell | |
dc.subject | priority journal | |
dc.subject | protein expression | |
dc.subject | symptom | |
dc.subject | Turkey (republic) | |
dc.subject | adult | |
dc.subject | autism | |
dc.subject | cell culture | |
dc.subject | clinical trial | |
dc.subject | immunity | |
dc.subject | metabolism | |
dc.subject | mononuclear cell | |
dc.subject | physiology | |
dc.subject | turkey (bird) | |
dc.title | Cytokine expression profiles in Autism spectrum disorder: A multi-center study from Turkey | |
dc.type | Article |